Recent Xarelto News

Xarelto Lawsuits Filed In Louisiana For Internal Bleeding Injury & Wrongful Death

Lawsuits are being filed across America in relation to the drug Xarelto after recently published studies showed a link between the prescription blood thinner and concerning side effects such as uncontrollable internal bleeding.

This article discusses basic information about Xarelto including pending litigation in Louisiana and how families are seeking justice throughout the country.

Xarelto: Everything To Know About The Drug & Pending Litigation

Xarelto (generic form: rivaroxaban) is a new type of blood thinner known as a Novel Oral Anticoagulant (NOAC) and is commonly prescribed for the prevention of blood clots in patients suffering from various medical conditions.

Traditional blood thinning medications, such as warfarin, require patients to undergo frequent blood testing and other maintenance procedures while using the drug. One of the major benefits of Xarelto however, is its low-maintenance requirements compared to traditional anticoagulants. Additionally, Xarelto touts a “one-size-fits-all” dose whereas many other blood thinners require doctors to prescribe a varying dosage for each patient depending on several factors.

These and other supposed benefits have helped to set Xarelto apart from other blood thinners on the market.

A Quick History Of Xarelto’s Success In The US Market


Xarelto is currently the leading blood thinner in its class in the US market with more than 11 million total prescriptions in America.

The Food and Drug Administration (FDA) approved Xarelto in 2011 for reducing the risk of blood clots, Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) in patients undergoing a knee replacement or hip replacement surgery.

The prescription blood thinner has since received approval for many other uses including the prevention of stroke in patients with Atrial Fibrillation (A-fib). Today the drug is approved for a total of six indications in the US.

However, recently published studies suggest a link between the popular drug and serious side effects such as severe internal bleeding.

Is Xarelto A Dangerous Drug?

As with any other anticoagulant drug, Xarelto users have a risk of experiencing severe internal bleeding.

However, Xarelto works differently than traditional blood thinners and has unique risks.

Whereas warfarin works to reduce blood clots by affecting certain vitamin k proteins involved in the blood clotting process, Xarelto works by acting on Factor Xa which is also involved in blood clotting.

A high dose of vitamin K is often prescribed to warfarin users to reverse the potentially dangerous effects of the blood thinner when excessive bleeding occurs.

Unfortunately, there is no “antidote,” or reversal agent known to reverse the effects of Xarelto. As a result, Xarelto users who experience internal bleeds can suffer from irreversible bleeding and lead to serious injury or even death.

Louisiana Lawsuits For Xarelto Side Effects

Xarelto’s blockbuster success over the last few years has resulted in the drug being prescribed to patients throughout the United States.

Recent findings linking Xarelto with severe bleeding have led affected individuals and families to take legal action by filing complaints in relation to the drug’s dangerous side effects.

The first complaint was filed on June 24th, 2014 by a Florida woman alleging that her husband’s death from a subdural hemorrhage was caused by Xarelto.

However, hundreds of additional complaints have been filed across the country over the last year. The increase in complaints has prompted consolidation of cases on both a federal and state level.

Louisiana Multidistrict Litigation (MDL)

A multi-district litigation was formed in the Eastern District Court of Louisiana in December 2014. The original MDL consisted of a few dozen complaints, however the total number of consolidated complaints has since grown to over 400.

The Multidistrict Litigation includes complaints filed in Federal District Courts around the country.

Estimated Bleeding Incidents In Louisiana

Many individuals in Louisiana have been prescribed Xarelto over the last few years. By weighing the State’s population relative to total US population, we estimate that out of all 11 million Xarelto prescriptions America, 160,334 of those were prescribed to individuals in Louisiana.

Furthermore, by using 1.7% incident rate of major bleeding (taken from AF clinical trials) we estimate that approximately 2,726 individuals in Louisiana suffered a bleeding injury or death that may be related to Xarelto.

We have also estimated the total bleeding incidents in Louisiana’s five largest cities to be:

  • New Orleans – 225
  • Baton Rouge – 135
  • Sheveport – 117
  • Metairie – 82
  • Lafayette – 74 Offering Free Case Evaluations is an online resource center sponsored by a group of Xarelto lawyers. Our team of attorneys are dedicated to helping individuals and families throughout the country by providing relevant information on pending Xarelto litigation, as well as access to legal guidance for those who wish to file a complaint.

We have already been contacted by people from all over the US who suffered an injury or lost a loved one due to an internal bleed that may be linked to Xarelto.

All of these incidents involved an individual who is currently or was once prescribed Xarelto.

If you or a loved one have suffered such an injury you may be entitled to compensation for damages in a Xarelto lawsuit.

We encourage you to contact us today for a free case evaluation.

Our team is here to help answer any questions that you may have and help you in your pursuit of justice.

Leave a Reply

Call Now Button